CompletedNot applicableNCT05392673

Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure.

Studying Acute liver failure

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Xiangya Hospital of Central South University
Principal Investigator
Wenting Peng
Xiangya Hospital of Central South University, Changsha, Hunan Province
Intervention
KM-8800 plasma exchange device (Kuraray, Tokyo, Japan)(other)
Enrollment
186 enrolled
Eligibility
18-65 years · All sexes
Timeline
20202021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05392673 on ClinicalTrials.gov

Other trials for Acute liver failure

Additional recruiting or active studies for the same condition.

See all trials for Acute liver failure

← Back to all trials